Have you heard? Viral-mediated gene therapy restores hearing
- PMID: 22841304
- PMCID: PMC4502432
- DOI: 10.1016/j.neuron.2012.06.008
Have you heard? Viral-mediated gene therapy restores hearing
Abstract
Genetic loss of VGLUT3 in cochlear inner hair cells results in profound deafness. In this issue of Neuron, Akil et al. (2012) show that AAV-mediated introduction of wild-type VGLUT3 in the genetically deaf mouse cochlea results in significantly improved hearing.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
Comment on
-
Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy.Neuron. 2012 Jul 26;75(2):283-93. doi: 10.1016/j.neuron.2012.05.019. Neuron. 2012. PMID: 22841313 Free PMC article.
References
-
- Akil, et al. 2012
-
- Cryns K, Van Camp G. Deafness genes and their diagnostic applications. Audiol Neurootol. 2004;9:2–22. - PubMed
-
- Lenz DR, Avraham KB. Hereditary hearing loss: from human mutation to mechanism. Hear Res. 2011;281:3–10. - PubMed
-
- Maeda Y, Fukushima K, Nishizaki K, Smith RJ. In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet. 2005;14:1641–1650. - PubMed
-
- Probst FJ, Fridell RA, Raphael Y, Saunders TL, Wang A, Liang Y, Morell RJ, Touchman JW, Lyons RH, Noben-Trauth K, et al. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science. 1998;280:1444–1447. [see comments]. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
